EUVIMED · CrossrefJournal
Current Opinion in Pharmacology
ISSN 1471-4892 · Elsevier BV
Latest articles
Advancing analgesic development for peripheral neuropathic pain: Multi-targeting sodium channels
NOD1 and neurodegenerative diseases: Exploring the interplay between innate immune signaling and cognitive decline
Clinical application progress of neural stem cells
Antibody-based Therapeutics for Asthma: Current perspectives
Antiviral Pressure and Viral Evolution: Lessons from Remdesivir, Molnupiravir, and Nirmatrelvir
Flavonoids for the Treatment of Corneal Neovascularization: Mechanistic Insights and Experimental Validation
NINJ1 as a terminal executor of lytic cell death: structure, mechanisms, disease relevance and therapeutic potential
One Health Surveillance in the Era of Artificial Intelligence: Lessons and Recommendations for Future Pandemic Preparedness
Systems pharmacology approaches to modeling immune training and tolerance
The neuro-metabolic epidemic and the CB1R paradox
Acupuncture and non-invasive neuromodulation–induced neuro-endocrine-immune changes associated with the amelioration of depression-like behaviors: A systematic review of animal studies
Alopecia areata: Mechanisms, targeted therapies, and translational challenges
Targeting the ischemic cascade: Review on approved and investigational stroke therapies
Senotherapeutic strategies for ovarian aging: Mechanistic insights and translational perspectives
Editorial Board
Research progress and prospect on the mechanisms of non-invasive neuromodulation therapy and acupuncture in treating cognitive impairment after traumatic brain injury
Orchestrating mitochondrial catastrophe: Mechanistic insights and therapeutic frontiers of cuproptosis in precision pharmacology
Riluzole in neuroinflammation and neurodegeneration: Mechanistic insights and experimental validation
Editorial Board
Advancements in targeted therapies for acute myeloid leukemia
Editorial Board
Electro-microbial interplay in the gut–brain axis: An emerging paradigm for gut microbiota modulation via vagus nerve stimulation
Innovative pipeline therapeutics in inflammatory bowel disease: Anti-tumor necrosis factor-like ligand 1A and bispecific antibodies
The underlying mechanisms of acupuncture for alleviating pain-induced negative emotions: Synergistic regulation of multiple brain regions
Modulating neuroimmune function: The key in taVNS therapy for neurological and psychiatric disorders
Modulating neuroinflammation through electroacupuncture: Mechanistic insights and pharmacological synergies
Ivermectin and non-parasitic disorders: An update
Targeting the unmet needs in IBD: Emerging therapies beyond biologics and small molecules
Immune cell subtype contributions to doxorubicin cardiotoxicity–defining immune targets for translational interventions
Recent innovations in clinical trial design for inflammatory bowel disease
EUVIMED